Moreover, a recent study utilized single-cell RNA sequencing to characterize the specific features associated with BTZ resistance in MM patients, highlighting the roles of MM-specific natural killer (NK) cells and T cells in determining responsiveness to BTZ treatment [6]. Here, CASC3 is linked to Miyoshi myopathy.